These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23057423)

  • 1. ART adherence changes among patients in community substance use treatment: a preliminary analysis from MACH14.
    Rosen MI; Black AC; Arnsten JH; Simoni JM; Wagner GJ; Goggin K; Remien RH; Golin CE; Wang Y; Bangsberg D; Liu HH;
    AIDS Res Ther; 2012 Oct; 9(1):30. PubMed ID: 23057423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of illicit drug use and substance abuse treatment on adherence to HAART.
    Hicks PL; Mulvey KP; Chander G; Fleishman JA; Josephs JS; Korthuis PT; Hellinger J; Gaist P; Gebo KA;
    AIDS Care; 2007 Oct; 19(9):1134-40. PubMed ID: 18058397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study.
    Simoni JM; Huh D; Wilson IB; Shen J; Goggin K; Reynolds NR; Remien RH; Rosen MI; Bangsberg DR; Liu H
    J Acquir Immune Defic Syndr; 2012 Aug; 60(5):466-72. PubMed ID: 22595873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.
    Mellins CA; Havens JF; McDonnell C; Lichtenstein C; Uldall K; Chesney M; Santamaria EK; Bell J
    AIDS Care; 2009 Feb; 21(2):168-77. PubMed ID: 19229685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of substance use and cognitive impairment on adherence to antiretroviral therapy in HIV+ patients.
    Sánchez-Rivero I; Madoz-Gúrpide A; Parro-Torres C; Hernández-Huerta D; Ochoa Mangado E
    Adicciones; 2020 Jan; 32(1):7-18. PubMed ID: 30627722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
    Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
    HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
    Kapadia F; Vlahov D; Wu Y; Cohen MH; Greenblatt RM; Howard AA; Cook JA; Goparaju L; Golub E; Richardson J; Wilson TE
    Am J Drug Alcohol Abuse; 2008; 34(2):161-70. PubMed ID: 18293232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.
    Lucas GM; Gebo KA; Chaisson RE; Moore RD
    AIDS; 2002 Mar; 16(5):767-74. PubMed ID: 11964533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression, substance abuse and other contextual predictors of adherence to antiretroviral therapy (ART) among Haitians.
    Malow R; Dévieux JG; Stein JA; Rosenberg R; Jean-Gilles M; Attonito J; Koenig SP; Raviola G; Sévère P; Pape JW
    AIDS Behav; 2013 May; 17(4):1221-30. PubMed ID: 23338563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.
    Grebely J; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Phung N; Weltman MD; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
    Addiction; 2016 Feb; 111(2):311-9. PubMed ID: 26451534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.
    Lucas GM
    Life Sci; 2011 May; 88(21-22):948-52. PubMed ID: 20888839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.
    Applebaum AJ; Reilly LC; Gonzalez JS; Richardson MA; Leveroni CL; Safren SA
    AIDS Patient Care STDS; 2009 Jun; 23(6):455-62. PubMed ID: 19519229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
    Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
    AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directly observed hepatitis C treatment with opioid substitution therapy in community pharmacies: A qualitative study.
    Gunn J; Higgs P
    Res Social Adm Pharm; 2020 Sep; 16(9):1298-1301. PubMed ID: 31003763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
    Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
    Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia.
    Uusküla A; Laisaar KT; Raag M; Šmidt J; Semjonova S; Kogan J; Amico KR; Sharma A; Dehovitz J
    AIDS Care; 2012; 24(12):1470-9. PubMed ID: 22533736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment.
    Shrestha R; Karki P; Huedo-Medina TB; Copenhaver M
    J Assoc Nurses AIDS Care; 2017; 28(1):85-94. PubMed ID: 27769735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.